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ABSTRACT
This article examines current health care policies and government practices that deter
appropriate end-of-life care, focusing on the use of hospice services for dying nursing home
patients. The authors conclude that hospice and nursing home regulations, reimbursement for
hospice and nursing homes, and enforcement of the fraud and abuse rules collude to “chill”
utilization of hospice by nursing homes and result in inadequate end-of-life care for many
nursing home patients. They argue that these policies and practices have at their roots a number
of questionable assumptions and call for a shift in existing paradigms affecting care to this group
and a realigning of incentives among these various government policies to achieve consistent
policy goals.

*This paper is an outgrowth of two empirical studies one funded by the Borchard Foundation on
Law and Aging and the other by the Donaghue Medical Research Foundation. It is being
published in a forthcoming issue of the Journal of Law, Medicine & Ethics.
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DYING IN AMERICA- AN EXAMINATION OF POLICIES THAT DETER ADEQUATE
END-OF-LIFE CARE IN NURSING HOMES

INTRODUCTION
The quality of end-of-life care in this country is often poor. There is abundant literature
indicating that dying individuals do not receive adequate pain medication or palliative care, are
tethered to machines and tubes in a way that challenges their dignity and autonomy, and are not
helped to deal with the emotional grief and psychological angst that may accompany the dying
process. While this is true for individuals in many settings, it seems to be especially true for
individuals in nursing homes. This is somewhat puzzling given that (1) considerable resources
have been devoted to bringing public attention to this problem, (2) we have the knowledge and
expertise to provide such care, and (3) we have a government-financed benefit that covers this
type of care – the Medicare hospice benefit (MHB).
While utilization of hospice care has increased during the last decade, there is
considerable evidence that hospice care remains underutilized particularly in the long term care
setting. There are a host of reasons for the lack of utilization, some are cultural and attitudinal,
some are based on a lack of awareness of the benefit, but others are arguably a result of
government policies and practices. These policies, particularly at the federal level, systematically
collude to inhibit adequate hospice care for dying nursing home patients. In this article we
examine the adverse, but largely unintended, consequences of these government policies and
practices, which include current Medicare regulations defining hospice eligibility and the type of
care that must be provided to nursing home residents, reimbursement for both hospice and
nursing home care, and the initiatives of the Office of the Inspector General (OIG) to combat
fraud in this area. We assert that at root these policies and practices are based on questionable
assumptions about such issues as where people die, the predictability of death, and the financial
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incentives of nursing homes to utilize hospice. As a result, we call for a shift in a number of
paradigms that have affected policies related to caring for nursing homes residents at the end-oflife. These include a shift from a singular focus on rehabilitation of nursing home patients to one
that encompasses palliation, and a change from viewing dying as a well defined event to viewing
dying as a process. We further argue that enforcers concerned about fraud and abuse in this
context need to temper an exclusive focus on deterrence of “over utilization” of services to one
that acknowledges underutilization. The result is that we need to reframe our policies and
practices in this area, realign the incentives for providers, and find the right balance in each of
these dyads.
BACKGROUND
Hospice Utilization in Nursing Homes
While nationally between 18% and 23% of all elderly people who die are enrolled in
hospice,1 numerous studies have shown that terminally ill residents of nursing homes have been
less likely to receive hospice services than individuals residing in their homes.2 Zerzan et al., in
a 2000 article published in the Journal of the American Medical Association, reported that
although “similar numbers of Medicare beneficiaries die in nursing homes and in private homes .
. . those who die at home are more likely to receive hospice care.”3 Although the percentage of

1

See BARBARA GAGE ET AL., DHHS, IMPORTANT QUESTIONS FOR HOSPICE IN THE NEXT CENTURY 1 (Mar. 2000),
available at http://www.aspe.hhs.gov/daltcp/reports/impques.pdf (stating that “[a]lmost 18 percent of all elderly
people who die are enrolled in hospice.”); see also LAST ACTS, MEANS TO A BETTER END: A REPORT ON DYING IN
AMERICA TODAY 16, at http://www.rwjf.org/news/special/meansReport.pdf (Nov. 2002); Diane E. Campbell et al.,
Medicare Program Expenditures Associated with Hospice Use, 140 ANNALS INTERNAL MED. 269, 269 (2004)
(stating that enrollment in the “Medicare hospice benefit increased from 9% in 1992 to 23% in 2000.”).
2
A national study published in 1999 found that only 1% of nursing home patients were enrolled in hospice at any
one time and that 70% of homes had no hospice patients enrolled. See Ann C. Petrisek & Vincent Mor, Hospice in
Nursing Homes: A Facility-Level Analysis of the Distribution of Hospice Beneficiaries, 39 GERONTOLOGIST 279
(1999); see also Davina Porock et al., A Profile of Residents Admitted to Long-Term Care Facilities for End-of-Life
Care, 4 J. AM. MED. DIRECTORS ASS’N 16 (2003) (finding that in Missouri in 1999 only 30% of certified long term
care facilities in the state provided hospice care to their residents).
3
Judy Zerzan et al., Access to Palliative Care and Hospice in Nursing Homes, 284 J. AM. MED. ASS’N 2489 (2000).
The observation is based on North Carolina hospice data which found that in that state in 1997, 19% of deaths
occurred in nursing homes and 22% in private homes but that during that year “only 13% of hospice enrollees were
in nursing homes, while 87% were in private homes.” See NORTH CAROLINA DIVISION OF FACILITY SERVS.,
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hospice enrollees in nursing facilities has increased significantly over the last few years, 4 several
sources indicate that hospice services remain underutilized in the nursing home setting and that
dying nursing home patients often do not receive adequate or appropriate end-of-life care.5
Moreover, there are data in some states indicating that nursing homes may not accurately
identify residents with end-of-life care needs and that those residents designated with such needs
may not receive hospice care.6 In addition, several recent studies have found that the hospice
average length of stay is shorter for patients with certain diagnoses that are more common in
nursing home patients.7

ANNUAL HOSPICE LICENSURE DATA SUPPLEMENT, 1997 (1997). Year 2000 data from the National Center for
Health Statistics indicated a similar utilization pattern at the national level. Of all deaths in 2000, 22% were in
nursing homes and 22.7% were in private residences. Of all deaths in that year of individuals 65 and older, 28.1%
were in nursing homes and 21.2% were in a private residence. NAT’L CTR. FOR HEALTH STATISTICS, DHHS, TABLE
309. DEATHS BY PLACE OF DEATH, AGE, RACE, AND SEX: UNITED STATES, 2000, at
http://www.cdc.gov/nchs/data/statab/mortfinal2000_work309.pdf (Mar. 21, 2003). Of those enrolled in hospice in
2000, 77% were in private residences and 18% were in health facilities (nursing home, hospital or other inpatient
facility). NAT’L CTR. FOR HEALTH STATISTICS, DHHS, TABLE 1. NUMBER, PERCENT DISTRIBUTION, AND RATE PER
100,000 POPULATION OF HOSPICE CARE DISCHARGES BY AGE, ACCORDING TO SEX, RACE, AND REGION: UNITED
STATES, 2000, at http://www.cdc.gov/nchs/about/major/nhhcsd/homecare2.htm#hospice (Feb. 2004). Year 2002
data from the National Hospice and Palliative Care Organization (NHPCO) confirm these earlier findings. NHPCO
reports that in 2002 about 25% of deaths occurred at home and 25% occurred in a nursing facility. In that same year,
of those served by hospice, 57.9% died at home and 21.5% died in a nursing facility. NHPCO Facts & Figures at
www.nhpco.org/files/public/Facts%20Figures%20Feb04.pdf (last updated Feb. 2004).
4
According to the MEDICARE PAYMENT ADVISORY COMM’N, REPORT TO THE CONGRESS: MEDICARE
BENEFICIARIES’ ACCESS TO HOSPICE 5, at
http://www.medpac.gov/publications/congressional_reports/may2002_HospiceAccess.pdf (May 2002), the
percentage of hospice enrollees in nursing homes increased from 11% in 1992 to 36% in 2000. However, according
to the NHPCO, in 2002, 21.5% of hospice patients died in a nursing home. See NHPCO Facts & Figures, supra
note 3. Yet, a more recent study by Campbell et al., supra note 1, indicated that 45% of hospice patients were
nursing home residents. The exact percentage of hospice enrollees in nursing homes is not readily available as this
information is not routinely collected as part of Medicare administrative data.
5
See Terrie Wetle et al., End-of-life in Nursing Homes: Experiences and Policy Recommendations, a report prepared
for AARP (forthcoming) (manuscript on file with authors); see also Robert J. Buchanan et al., End-of-Life Care in
Nursing Homes: Residents in Hospice Compared to Other End-Stage Residents, 7 J. PALLIATIVE MED. 221 (2004);
Debra Parker-Oliver et al., End-of-Life Care in U.S. Nursing Homes: A Review of the Evidence, 5 J. AM. MED.
DIRECTORS ASS’N 147 (2004); Mary Beth Happ et al., Advance Care Planning and End-of-life Care for Hospitalized
Nursing Home Residents, 50 J. AM. GERIATRICS SOC’Y 829 (2002).
6
See Debra Parker-Oliver et al., Hospice and Nonhospice Nursing Home Residents, 6 J. PALLIATIVE MED. 69
(2003).
7
See MEDICARE PAYMENT ADVISORY COMM’N, supra note 4, at 6 (stating that certain diagnoses, such as congestive
heart failure and myocardial infarction, “significantly predicted admission to hospice within two weeks of death”);
see also Campbell et al., supra note1, at 274 (stating that “entry to hospice in the last week of life was more
prevalent among enrollees without cancer than those with cancer” 36% v. 23%); Susan C. Miller et al., Hospice
Length of Stay in Nursing Homes and Factors Influencing Short Stays, 40 GERONTOLOGIST 302 (2002) (finding that
in nursing homes, residents with dementia and diagnoses other than cancer or dementia were found to have hospice
lengths of stay of one week or less.)
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Structure of the Benefit
The hospice philosophy embraces a holistic approach to support individuals and families
at the end-of-life, providing physical pain and symptom management as well as psychological
and spiritual support from a team of volunteers and health care professionals. To be eligible for
the MHB, the patient’s physician and the hospice medical director or a physician member of the
hospice interdisciplinary team must certify that the patient is terminally ill8 (with a life
expectancy of six months or less9 if the disease “runs its normal course.”)10 After the first 90 day
period, the second 90 day period, and for every 60 day period thereafter that the patient remains
in hospice, one of the hospice physicians must certify that the patient is terminally ill.11 A patient
may remain in hospice for an unlimited number of 60 day periods as long as the hospice
physician certifies that he or she is terminally ill.12 Individuals who elect the MHB also waive
coverage of all Medicare funded curative care related to the patient’s terminal illness as well as
care that would be duplicative of hospice care.13 Medicare will continue to pay, however, for a
beneficiary’s covered medical needs unrelated to the terminal condition.14

8

See 42 U.S.C.A. § 1395f(a)(7) (West Supp. 2004).
See 42 U.S.C.A. § 1395x(dd)(3)(A) (West Supp. 2004).
10
42 C.F.R. § 418.22 (b) (2003).
11
See 42 U.S.C.A. § 1395f(a)(7) (West Supp. 2004) (stating that a hospice physician and the patient’s attending
physician must certify a patient as “terminally ill” “in the first 90 day period” and that a hospice physician must
certify the patient as terminally ill “in a subsequent 90- or 60-day period . . .”). When initially enacted, the Medicare
Hospice Benefit included a 210 day limit. This included two 90 day periods and a third 30 day period. However,
Congress repealed the limit effective for services furnished on or after January 1, 1990 in the Medicare Catastrophic
Coverage Repeal Act of 1989. See OIG, HOSPICE PATIENTS, infra note 71, at I (stating that “[t]he repeal of the 210
day limit shifted the financial risk for patients living longer than 210 days from the hospice to Medicare . . . Before
the repeal of the 210 day limit for hospice care, hospices would have to provide uncompensated care for patients
who lived beyond 210 days and continued to require hospice care.”) Id. at 11.
12
See 42 U.S.C.A. § 1395d(d)(1) (West Supp. 2004) (stating that payment for hospice care may be made “with
respect to an individual only during two periods of 90 days each and an unlimited number of subsequent periods of
60 days each . . .”).
13
See 42 U.S.C.A. § 1395d(d)(2)(A) (West Supp. 2004).
14
See Medicare Program; Hospice Care Amendments, 67 Fed. Reg. 70,363, 70,364 (Nov. 22, 2002).
9
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The MHB must be delivered by an interdisciplinary team including a physician,
registered nurse, social worker, and pastoral or other counselor.15 This team, with the patient, the
patient's family and the patient's primary or attending physician
assesses, coordinates, and provides the appropriate palliative and supportive care
to hospice patients and their families. Additionally, the . . . team helps establish
the patient's plan of care, providing or supervising hospice care and services, and
periodically reviewing and updating the care plan. The team also manages the
patient's discomfort and symptom relief.16
Volunteers are also used to provide home visits.17 The hospice physician and nurse are on call 24
hours a day, seven days a week to provide consultation by phone or in person, if necessary.18 In
addition to providing these services to dying patients, hospice also provides bereavement
services to a patient’s family members after the patient has died.19
Under the MHB there are four levels of care and corresponding per diem payment rates:
(1) routine home care which is care delivered in the patient’s home; (2) continuous home care,
i.e., care delivered at a patient’s home requiring a minimum of eight hours of care per day (half
of which must be actual nursing care), (3) inpatient respite care or care for which the hospice
must make the financial arrangements for the hospitalization of a hospice patient in either a
hospital, hospice inpatient facility, or a skilled nursing facility (SNF) when necessary to relieve
the caregivers at home, and (4) general inpatient care, provided in either a hospital, hospice
inpatient facility, or a SNF for pain control or acute or chronic symptom management which

15

See 42 C.F.R. § 418.68(a) (2003); 42 U.S.C.A. § 1395x(dd)(2)(B) (West Supp. 2004).
GAGE ET AL., supra note 1, at 5-6.
17
See 42 C.F.R. § 418.70 (2003); 42 U.S.C.A. § 1395x(dd)(2)(E) (West Supp. 2004). The initial hospice legislation
required hospices to use volunteers and mandated “records on their use, cost savings, and the expansion of care and
services achieved by doing so.” GAGE ET AL., supra note 1, at 6.
18
See 42 C.F.R. § 418.50 (2003). The MHB includes a number of benefits not available under other Medicare
programs such as “non-IV therapy outpatient prescription drugs for pain relief and symptom management,
homemaker services, and bereavement counseling for both the patient and their family members.” GAGE ET AL.,
supra note 1, at 8.
19
See 42 C.F.R. § 418.88 (2003).
16
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cannot be managed in another setting. The FY 2004 reimbursement rates for these levels of care
ranged from $118 for routine home care to $689 for continuous home care.20
While Congress established the Medicare Hospice Benefit (MHB) in 1982,21 it was not
until 1986 that the MHB was made available to nursing home residents.22 Most nursing home
residents eligible for hospice are over sixty-five and thereby qualify for the MHB.23 For purposes
of the MHB, the nursing home is considered the patient’s home and the majority of care
provided in the nursing home is level one, routine home care.
When a nursing home resident elects the MHB, the hospice takes on responsibility for the
professional management of the patient’s care for his or her terminal condition. Certain core
services, including nursing care, physician services, medical social services, and counseling must
be provided directly by the designated hospice provider.24 Other services, including physical
therapy, occupational therapy, speech-language pathology services, home health aide and
homemaker services, and medical supplies (including drugs and biologicals for palliation and
management of the terminal illness) must be provided either directly by hospice employees or by
arrangement with other providers.25 For these services, the Medicare program pays the hospice
provider based on the routine home care rate unless the beneficiary qualifies for a higher level of
care.
The nursing home continues to provide the patient’s room and board and other services
unrelated to care of the patient’s terminal illness. In addition to lodging and food, for residents
20

See Centers for Medicare & Medicaid Services, DHHS, Program Memorandum: Medicare Program–Update to the
Hospice Payment Rates, Hospice Cap, Hospice Wage Index and the Hospice Pricer for FY 2004 (CMS Pub. 60A,
Transmittal A-03-057), at http://www.cms.hhs.gov/manuals/pm_trans/a03057.pdf (July 3, 2003).
21
See Tax Equity and Fiscal Responsibility Act (TEFRA) of 1982 § 122, Pub. L. No. 97-248, 96 Stat. 324, 356-63
(codified as amended in scattered sections of 26 and 42 U.S.C.).
22
See Omnibus Budget Reconciliation Act of 1986, Pub. L. No. 99-509, 100 Stat. 1874.
23
Those who are not Medicare eligible may have private insurance that covers hospice care or may be eligible for
the Medicaid hospice benefit. The majority of state Medicaid programs cover hospice services. Medicaid requires
that, if a state does provide hospice services, state programs include “at minimum” the same services covered by
Medicare. See GAGE ET AL., supra note 1, at 13.
24
See 42 C.F.R. §§ 418.80 - 418.88 (2003) (outlining core services that must be provided by the hospice).
25
See 42 C.F.R. § 418.56 (2003) (specifying terms for services provided by arrangement with other entities) and §§
9

who are dually eligible for Medicare and Medicaid, room and board includes “performance of
personal care services, assistance in activities of daily living, socializing activities,
administration of medication, maintaining the cleanliness of a resident’s room and supervising
and assisting in the use of durable medical equipment and prescribed therapies.”26
Benefits of Hospice for NH Patients
Nursing home residents in hospice, as compared to those who do not receive hospice
services, may receive better pain control, “better relief of dyspnea, fewer uncomfortable
symptoms of dying, better attention to hygiene, better total comfort, and better bereavement
support.”27 A study commissioned by DHHS, made publicly available in March 2000, compared
two cohorts of nursing home patients at the end-of-life—hospice and non-hospice. The data were
from 1992 - 1997 and included 2,655 hospice patients and 7,929 non-hospice patients matched
on time interval between last Minimum Data Set and death, diagnostic group, and state of
nursing home residence. The researchers concluded that nursing home patients enrolled in
hospice, when compared to those at the end-of-life who were not in hospice:
•

were significantly less likely to be hospitalized in their last six months of life,

•

received superior pain assessment since pain was more likely to be detected,

•

if in pain, were more likely to be treated with pain medication, and

•

were less likely to be physically restrained or have feeding tubes. 28

The study further found that hospice staff served an important educational function in the nursing
418.90 -.100.
26
CENTERS FOR MEDICARE & MEDICAID SERVICES, HOSPICE MANUAL, PUB. 21, REV. 55 § 204.2, at
http://www.cms.hhs.gov/manuals/21_hospice/hs200.asp (Last modified on July 30, 2003).
27
Timothy J. Keay & Ronald S. Schonwetter, The Case for Hospice Care in Long Term Care Environments, 16
CLINICS IN GERIATRIC MED. 211 (2000).
28
See SUSAN C. MILLER ET AL., DHHS, OUTCOMES AND UTILIZATION FOR HOSPICE AND NON-HOSPICE NURSING
FACILITY DECEDENTS, at http://www.aspe.hhs.gov/daltcp/reports.shtml (Mar. 2000). The study used the Minimum
Data Set (MDS) and Medicare enrollment and claims data for the states of Kansas, Maine, Mississippi, New York
and South Dakota.
10

home and often had a “beneficial spillover” effect, improving the care of non-hospice, terminally
ill patients in the facility.29
BARRIERS TO HOSPICE UTILIZATION IN LONG TERM CARE
Attitudes, Culture and Awareness
There is a significant body of literature alleging that failure of nursing homes to utilize
hospice can be attributed to lack of knowledge of and attitudes toward the benefit on the part of
patients, families, and nursing home staff and administrators, as well as cultural differences
between the two providers. As regards attitudes of nursing home administrators, one study of 23
nursing homes in the same state found that rates of hospice use varied by facility from 2% to
39%.30 Upon further research, the authors concluded that the most significant factor accounting
for the differences seemed to be whether or not the nursing home administrator was sympathetic
to hospice care. Administrators who were not sympathetic to hospice had the following views in
common:
(1) nursing homes were doing a good job with terminal patients before hospice was
available and therefore hospice was not really needed;
(2) hospice had been imposed without appreciation for the procedural problems and costs
involved;
(3) hospice practices might get too close to euthanasia;
(4) uncertainty about the financial implications of assigning a Medicare patient to
hospice.31
Others have described the institutionalized culture of the nursing home as in sharp
contrast to the individualistic approach of hospice:

29

Id.
See Bent Jones et al., Differential Utilization of Hospice Services in Nursing Homes, 12 HOSPICE J. 41 (1997).
31
See id.
30
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Hierarchical staffing structures with high turnover and staff burnout are typical of
the nursing home, while hospice agencies promote a democratic system which
includes family and volunteers. The nursing home generally focuses on custodial
care and assisting in the activities of daily living, while hospice emphasizes
psychosocial and spiritual needs. With hospice care, pain control is concerned
with preventing pain through regular liberal dosages [of pain medication] rather
than responding with minimal dosages after pain has already occurred. In hospice
services, open communication about death and bereavement is encouraged and
supported, while the nursing home environment provides little if any training or
discussion about death and grief.32
Government Policies and Practices
While attitudes, knowledge and culture are part of the problem, there are also numerous
assertions in the literature that other factors are at work, including government practices and
policies to deter utilization of hospice services in the long term care setting. These have
included: (1) Medicare nursing home regulations that focus on rehabilitation and restoration in
contrast to palliation; (2) the six month life expectancy eligibility criteria for the MHB; (3)
reimbursement schemes for hospice and nursing homes that encourage skilled nursing care over
the MHB; and (4) scrutiny by the OIG of hospice referrals to nursing homes and contractual
relationships between these two providers. These government policies and actions arguably
reinforce the cultural and attitudinal barriers to use of hospice.
Regulations
The Medicare statute explicitly states that a nursing home must provide services “to
attain or maintain the highest practicable physical, mental and psycho-social well-being of each
resident. . .”33 Several commentators have alleged that this approach to care, which encourages
“aggressive rehabilitation, medical treatment and maintenance of functional capacity”34 may
conflict with the needs of dying patients and result in “unsatisfactory care at the end-of-life with
32

Id. at 45, citing Anne Munley et al., Humanizing Nursing Home Environments: The Relevance of Hospice
Principles, 15 INT’L J. AGING & HUM. DEV. 263 (1982).
33
42 U.S.C.S. §§ 1395i-3 (a)-(h) and 1396r (a)-(h) (2003).
34
NATIONAL HOSPICE ORGANIZATION, NURSING HOME TASK FORCE REPORT (hereinafter NHO REPORT) 6 (1998).
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pain and other distressing symptoms inadequately managed, and failure to address spiritual and
emotional needs.”35
Johnson observes that the nursing home regulations implementing the statutory
requirements “impose standards that assume that physical, mental, and emotional decline may
be indicators of deficiencies in care of elderly residents.”36 Furthermore, the regulations
mandate the “use of a comprehensive, uniform assessment system”37 -- the Resident
Assessment Instrument-- which explicitly culls out for further investigation any evidence of
resident decline. As a result, physical, mental and emotional changes that often accompany the
normal dying process may be identified as deficiencies.38 An example often mentioned by
hospice staff is a patient’s unwillingness to eat. Hospice staff view this as a natural part of the
dying process but they find that nursing home staff are often concerned with the possibility of
“being cited for substandard care if a resident is malnourished or dehydrated.”39 This results in
feeding tube use for many dying residents “despite the lack of evidence demonstrating any
health benefits from this intervention.”40
Kapp has asserted that nursing home administrators’ and providers’ sensitivity to legal
risk makes them much more likely to err on the side of maintenance and restoration of function
than comfort care in the context of dying patients.41 They do not wish to attract the attention of
surveyors who might perceive weight loss or inadequate nutrition of a patient as an indication
of inadequate care.

35

Parker-Oliver, supra note 5 at 147, citing Timothy J. Keay, Palliative Care in the Nursing Home, 23
GENERATIONS 96 (1999).
36
Sandra H. Johnson (forthcoming, manuscript on file with the authors)
37
Marshall B. Kapp, Legal Anxieties and End-of-Life Care in Nursing Homes, 19 ISSUES IN LAW & MED. 111,128
(2003).
38
See Johnson, supra note 36; see also Zerzan, et al., supra note 3.
39
GAGE ET AL., supra note 1 at 60.
40
Susan C. Miller and Vincent Mor, The Opportunity for Collaborative Care Provision: The Presence of Nursing
Home/Hospice Collaborations in the U.S. States, 28 J. PAIN & SYMPTOM MGT. 537 (2004).
41
See Kapp, supra note 37.
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In one study, nursing facility staff and hospice professionals stated that the nursing home
“orientation” makes it difficult for “nursing facility staff to switch between providing
restorative rehabilitative care and palliative care.”42 This difference in focus also affects the
administration of narcotics, which hospice staff view as a necessary tool for pain management
and may prescribe in large doses and/or on a fixed schedule. Nursing home staff fear, however,
that this may be seen as “overmedication” by nursing home surveyors or as a violation of
nursing home regulations that prohibit the use of chemical restraints.43
Hospice regulations may also contribute to the infrequent referral of nursing home
patients to hospice. Here, the obstacle has been the requirement that physicians certify a patient
as having an estimated life expectancy of six months or less. While this concern is not unique to
patients residing in nursing homes, the requirement has historically favored referral of cancer
patients whose disease trajectory is relatively predictable, and disfavored those for whom the
trajectory of their illness and death is relatively unpredictable—e.g., individuals with congestive
heart failure or Alzheimer’s disease. Nursing home residents are more likely to be in this latter
group.
Reimbursement Issues
The reimbursement systems under Medicare for hospice and nursing homes, in particular
the SNB, may also add to the host of disincentives for hospice use by long term care facilities.
The per diem payment scheme for each arguably reinforces structural anachronisms in the
Medicare program that require individuals to choose between curative and palliative care and
that encourage rehabilitation over palliation. Moreover, for residents who are eligible for both

42

GAGE ET AL., supra note 1, at 59.
“Chemical Restraints” is defined by the regulations as “any drug that is used for discipline or convenience and not
required for treatment of medical symptoms.” 42 C.F.R. § 483.13(a).
43
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Medicare and Medicaid, the per diem reimbursement for the MHB and Medicaid room and board
has created confusion over which provider is responsible for some services.
In order to be eligible for the SNB, a patient must have been discharged to the nursing
home from a hospital with a minimum three day stay and must need skilled nursing care. The
benefit is available for up to100 days of skilled care and covers medical care as well as the
resident’s room and board.44 In general, a nursing home resident who is eligible for both the SNB
and the MHB must choose one or the other.45 When a resident qualifies for the SNB for
treatment of a terminal illness, even if he or she is also eligible for, and may prefer, hospice care,
the resident and her family may be reluctant to elect the MHB as, in contrast to the situation
under the SNB, the MHB does not cover room and board. Thus, unless the resident is also
Medicaid eligible or has other health insurance that would cover the room and board cost, the
resident would be saddled with paying this cost out of pocket.46 These residents may forgo the
hospice services they want and need due to the financial incentive to elect the SNB.
Residents who are Medicaid eligible would theoretically be financially indifferent to the
SNB and the MHB as both their medical care and room and board would be covered by a third
party payer. The nursing facility, however, may not be indifferent between the two benefits but,
in many cases, may prefer that the resident receive the SNB as it would be financially

44

Medicare covers 100% of the first 20 days of skilled care. For days 21–100, patients are required to pay a
coinsurance amount equal to one eighth of the Medicare inpatient hospital deductible. See 42 U.S.C.A. §
1395e(a)(3) (West 2003). For FY 2004 this was approximately $110.
45
Under certain limited circumstances, a nursing home resident may be eligible for both the Medicare Skilled
Nursing Benefit (SNB) and the MHB. The resident may receive both at the same time if the SNB involves care for a
non-terminal condition, e.g., a patient with breast cancer may receive speech therapy after a stroke. However, if the
care is exclusively for treatment of a terminal condition, the resident may only receive one benefit at a time. For
example, if the patient is terminally ill with congestive heart failure (CHF) and is returning to the nursing home after
a hospital visit for treatment of an acute episode s/he may be eligible for both the SNB and the MHB for care related
to the CHF. However, the patient may choose only one of these benefits for treatment of this condition. In some
cases, there is not a bright line indicating whether or not treatment under the SNB is related to a terminal condition.
For example, a cancer patient may experience a series of bone fractures. These may or may not be related to
brittleness caused by the cancer or cancer therapy.
46
In 2002, the average nationwide private pay per diem rate was $142.56 for a semiprivate room and $167.82 for a
private room. See MATURE MARKET INST., METLIFE, INC., METLIFE MARKET SURVEY ON NURSING HOME AND
HOME CARE COSTS 6, at
http://www.metlife.com/WPSAssets/83700920001018640690V1FNH%20HC%20Survey%202002.pdf (Apr. 2002).
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advantageous to the facility. If a resident receives the SNB, the facility will receive a per diem
rate based on the skilled nursing facility (SNF) prospective payment reimbursement system.
Under this system, the specific rate will depend on the particular RUGs (resource utilization
group) category of the patient. Per diem reimbursement for all RUGs categories in 2004 was at
least $140 per day, for most it was over $200, and for some it was more than $400.47 Nursing
facilities would compare this payment to the per diem they would receive for room and board
from Medicaid when the patient receives the MHB. If a patient is dually eligible for Medicare
and Medicaid, the hospice is reimbursed for its medical services by Medicare and is reimbursed
for the nursing home room and board charges by Medicaid at a rate equal to at least 95% of the
established room and board rate for nursing homes. The hospice then, pursuant to a contract,
reimburses the nursing home in amounts between 95% and 100% of the Medicaid room and
board rate for providing the nursing home services.48 In 2002, the average per diem nursing
home rate was $265 for Medicare residents49 and $118 for Medicaid residents.50
The possibility that nursing homes may be steering patients to the Medicare SNB when
residents qualify for, and may be more appropriately placed in, hospice because the SNB pays
more than the Medicaid room and board per diem is troubling. While the issue of “steering”
would be difficult to assess due to mixed motives of both patients and nursing facilities, there is
clearly a financial incentive for nursing facilities to engage in such behavior.
While this financial incentive has been mentioned in the literature as an obstacle to
hospice use by many nursing homes, it is not clear how many nursing home residents are
47

See Medicare Program; Prospective Payment System and Consolidated Billing for Skilled Nursing Facilities—
Update - Notice, 69 Fed. Reg. 45,775 – 45,822 (July 30, 2004).
48
The Omnibus Budget Reconciliation Act of 1989 provided that the hospice payment to nursing facilities “take into
account the room and board furnished by the facility, equal to at least 95 percent of the rate that would have been
paid by the State under the plan for facility services in that facility for that individual.” Codified at 42 U.S.C.A.
§1396a (a)(13)(B) (West Supp. 2004).
49
CMS, “Medicare Skilled Nursing Facility (Non-Swing Bed) Utilization and Expenditure Calendar year 2002.”
(The figure does not include beds that “swing” between hospital and SNF levels of care.)
50
David C. Grabowski, et al., Project HOPE; “Recent Trends in State Nursing Home Payment Policies,” Health
Affairs Web Exclusive, June 16, 2004 at http://content.healthaffairs.org/cgi/content/full/hlthaff.w4.363/DC1.
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simultaneously eligible for the Medicare skilled benefit, the MHB, and Medicaid. However, a
March 2000 report prepared for DHHS, based on 9,299 nursing home residents who had at least
one hospice episode, found that 73% had received care under the SNB at some point prior to
hospice admission. The time between SNF discharge, i.e., termination of the SNB, and hospice
admission varied significantly but 26% were admitted to hospice within 0 to 1 day after SNF
discharge.51 The study authors state that the data “suggests that hospice care may have been
appropriate earlier if it were available to patients in SNF beds.”52
A second reimbursement issue that may deter hospice and nursing homes from
collaborating is confusion created by the overlap in services covered by the per diem hospice
benefit and the per diem nursing home payment for room and board. For “dual eligibles,” i.e.
individuals who are eligible both for Medicaid and the Medicare hospice benefit, it is not clear
which entity is responsible for some services because the per diem of each covers those services.
Examples include “personal health services” and drugs used in connection with a terminal
illness. The MHB covers services necessary for the palliation or management of terminal
illness.53 Included in these services are home health aide services which encompass “personal
care services.”54 The nursing home Medicaid per diem for room and board also includes personal
care services.55 Based on concerns expressed by the OIG that hospices were providing fewer
services to residents in the nursing home than in the community, some hospice providers have
asked whether they should be providing the same services to nursing facility residents that they
provide to patients in the community even if it means duplicating services provided by the
nursing home staff.
51

See SUSAN C. MILLER ET AL., DHHS, USE OF MEDICARE’S HOSPICE BENEFIT BY NURSING FACILITY RESIDENTS, at
Skilled Nursing Facility Care and Hospice Admission (Mar. 2000), available at
http://www.aspe.hhs.gov/daltcp/reports/nufares.htm.
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Id.
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See 42 CFR § 418.200.
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See 42 CFR § 418.204(g).
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In May 2002, CMS issued a guidance memorandum to State Medicaid Directors
regarding the responsibility of each provider for the implementation of the MHB for nursing
home residents.56 The memorandum was subsequently incorporated into the Medicaid State
Operations Manual.57 This guidance affirms that hospice services must be provided “at the same
level” to nursing home residents as to patients residing in their home, however it is not explicit as
to how comparability is to be determined.
A similar issue is created by payment for drugs used by “dually eligibles” in connection
with their terminal illness. The MHB covers drugs used for palliation and management of a
patient’s terminal illness and related conditions.58 In addition, the Medicaid per diem payment in
some states may include the provision of such drugs. Under these circumstances, one hospice
provider asked for an OIG Advisory Opinion as to whether a hospice can pay a nursing home
above the Medicaid per diem rate for drugs in connection with a patient’s terminal illness. The
OIG responded that in the circumstances presented the arrangement could “involve prohibited
remuneration under the anti-kickback statute” but that there was insufficient information
provided by the hospice to determine whether there was an actual violation.59 Uncertainty
regarding potential legal risk created by these unclear payment rules may also deter nursing
homes from utilizing hospice services.
Enforcement of Fraud and Abuse Rules
The fraud and abuse concerns for nursing homes referring patients to hospice arise at two
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See Medicare Hospice Manual CENTERS FOR MEDICARE & MEDICAID SERVICES, HOSPICE MANUAL, PUB. 21, REV.
Sec. 204.2 at http://www.cms.hhs.gov/manuals/21_hospice/hs200asp .
56
See Memorandum from Steven A. Pelovitz, Director, Survey and Certification Group, Center for Medicaid and
State Operations to Associate Regional Administrator, DMSO, and State Survey Agency Directors, Promising
Practices for Implementing the Medicare Hospice Benefit for Nursing Home (NH) Residents, (Ref: S&C-02-29),
available at http://www.cms.hhs.gov/medicaid/survey-cert/sc0229.pdf (May 10, 2002).
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See CENTERS FOR MEDICARE & MEDICAID SERVICES, PUBLICATION 100-7, STATE OPERATIONS MANUAL § 2082,
available at http://www.cms.hhs.gov/manuals/107_som/som107c02.pdf (last modified June 18, 2004).
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See 42 C.F.R. § 418.96.
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OIG Advisory Opinion No. 01-20 (2001) at
http://www.oig.hhs.gov/fraud/docs/advisoryopinions/2001/ao00_3.htm
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levels. The first is whether the nursing home enters into a formal contractual agreement with a
hospice or hospices to refer their terminally ill patients for hospice care. This is significant as
“facilities that do not contract with a participating hospice may not make the benefit available to
their residents.”60 The second is whether, on a case-by-case basis, the nursing home will refer a
specific nursing home resident to a hospice program.
As regards the latter, some have attributed hesitancy on the part of health care providers
to refer a patient to hospice when they are not extremely certain of the patient's life expectancy
because they fear it would violate fraud and abuse laws. Such fear has not been without merit. In
1995, the OIG, under the name Operation Restore Trust, began a series of investigations of fraud
and abuse in home health agencies, nursing homes, durable medical equipment companies and
hospice organizations. The inclusion of hospice came after audits of two Puerto Rican hospices
found that 77 percent of one hospice's patients were ineligible because they were not terminally
ill and after an audit report of a Florida hospice, released in 1996, claimed that the hospice erred
in admitting 176 patients out of 364 patients who were either enrolled for more than 210 days or
had been discharged alive over a 27-month period. This prompted the OIG to look more closely
at the practices of other hospices and in April 1998, the OIG issued a report on Medicare
Hospice Beneficiaries.61 The report, based on inspections of 36 hospice agencies, found that a
significant portion of hospice patients in nursing homes were not eligible for the MHB because
they were not considered to be “terminally ill.” The results of the report were controversial and
disputed by the hospice industry. In its comments on a draft of the OIG report, the National
Hospice Organization (NHO) stated that it “continues to be distressed by the OIG’s
characterization of patients being ineligible for the Medicare hospice benefit where differences in
medical opinion related to the prognosis of a patient exist between OIG reviewers and the
60
61

GAGE ET AL., supra note 1, at 2.
See OFFICE OF INSPECTOR GEN., DHHS, MEDICARE HOSPICE BENEFICIARIES: SERVICES AND ELIGIBILITY (OEI-0419

patient’s attending physician and hospice medical director. The well-regarded Institute of
Medicine has very clearly warned the OIG not to draw conclusions about the veracity of hospice
programs based on these differences of medical opinion.”62
An article in The Wall Street Journal, published in June 2000, provides some indication
of the scrutiny the OIG has applied to hospices and hospice patients and would appear to support
an argument that the OIG’s actions may have had a chilling effect on referrals to hospice—
especially for patients for whom the disease trajectory is difficult to predict.63 According to the
article, in February 1997, five hospice patients and a hospice provider received a letter warning
that the Medicare beneficiaries might each owe Medicare tens of thousands of dollars. The
beneficiaries were mostly in their 80s and 90s, had been diagnosed as terminally ill, had been
treated by a local hospice and, most significantly, their life spans had exceeded the six month
guideline for determination of terminal illness. The total amount that the five patients were
expected to pay back was $450,000. The letters told the recipients: “You are not eligible for the
Medicare hospice coverage” and added that “Medicare will recoup the money that it
inappropriately paid.” The hospice challenged Medicare’s decision to recoup the funds and a
hearing on the case was held in September 1998. The administrative law judge held for the
hospice provider and beneficiaries, stating that there was good reason to believe that the patients
were terminal when they were admitted and that the fact that some patients, “exceeded those
expectations does not indicate that a fraud was perpetrated.” The government appealed the
decision and lost.

93-00270, Apr. 1998), available at http://oig.hhs.gov/oei/reports/oei-04-93-00270.pdf.
62
Letter from John J. Mahoney, President, National Hospice Organization to the Hon. June Gibbs Brown, Inspector
General, DHHS (Jan. 29, 1998).
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See Lucette Lagnado, Rules Are Rules: Hospice’s Patients Beat the Odds, So Medicare Decides to Crack Down,
WALL ST. J., June 5, 2000, at A1.
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In order to protect beneficiaries from similar future government actions, as part of the
1997 Balanced Budget Act, Congress extended limitation on liability protection64 to a
beneficiary enrolled in a hospice “where there is a denial of claims due to a determination that
the individual is not terminally ill.”65 Also, in 2000, Congress clarified the requirement for
certification of terminal illness to make it clear that physicians could make this decision based on
the physician’s clinical judgment regarding the normal course of the individual’s illness.66 This
statutory change, although consistent with prior DHHS policy,67 was made to make it clear to
physicians that they could base their judgment on the typical course of a given illness rather than
on whether a specific individual would live more than six months.68
While these changes may have made hospice physicians and nursing homes more
comfortable with referring patients to hospice, the practice of Medicare fiscal intermediaries
(FIs) of scrutinizing cases in which patients live longer than 6 months may have reinforced
concerns about referrals to hospice of patients with diagnoses for which it is difficult to predict
life expectancy. 69 In such cases, the FIs may withhold reimbursement until satisfied that the
beneficiary meets the FI’s criteria for terminal illness.
64
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See Medicare Program; Hospice Care Amendments, 67 FED. REG. 70,363 - 70,364 (Nov. 23, 2002).
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The fraud and abuse concerns related to contractual arrangements have received less
discussion in the literature than those regarding individual referrals and whether a patient meets
the hospice eligibility requirement that a patient have an estimated life expectancy of six months
or less.70 Yet, a 1998 OIG fraud alert regarding contracts between nursing homes and hospice
may have also affected referrals of nursing home residents to hospice. The alert was prompted by
a substantial increase in Medicare payments for hospice services, including those provided to
beneficiaries residing in nursing facilities, and by the results of two studies published in 1997 by
the Office of the Inspector General (OIG).71
In its 1998 fraud alert, the OIG asserts that arrangements between nursing homes and
hospices are vulnerable to fraud and abuse because nursing home staff often decide whether to
bring hospice services into their facility for a terminally ill resident.72 The OIG believes patients
residing in nursing homes may be particularly desirable from a hospice's financial standpoint
because they represent a sizeable pool of potential hospice patients with (according to the OIG)
month life expectancy for a beneficiary who has been in hospice for many certification periods is more likely
accurately made by reviewing that patient’s trend toward decline, stability, or improvement and not by the LCD
criteria.” See also LCD for Hospice – Determining Terminal Status for the Cataba fiscal intermediary at
http://www.iamedicare.com/Provider/policy/L13653.htm.
70
A March 2000 report prepared for DHHS by the Urban Institute stated: “According to anecdotal reports, access to
hospice care in the nursing facility may have become more difficult since the . . . OIG . . . questioned the hospice
lengths of stay and eligibility of beneficiaries residing in nursing facilities.” GAGE ET AL., supra note 1 at 1-2.
71
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http://oig.hhs.gov/oei/reports/oei-05-95-00250.pdf (Sept. 1997) [hereinafter OIG, HOSPICE PATIENTS] (finding that
nursing home hospice patients in a sample of 22 hospices received fewer nursing and aide services from hospice
staff than hospice patients living at home and that many of these services were also provided by the nursing home
staff when hospice staff were not present). An initial draft of this report recommended that the Medicare hospice
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elected hospice.”); OFFICE OF INSPECTOR GEN., DHHS, ENHANCED CONTROLS NEEDED TO ASSURE VALIDITY OF
MEDICARE HOSPICE ENROLLMENTS (A-05-96-00023), at http://oig.hhs.gov/oas/reports/region5/59600023.pdf (Nov.
4, 1997). The latter finding was based on 17 contracts between hospice organizations and nursing homes. The OIG
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Memorandum from David F. Garrison, Principal Deputy Assistant Secretary for Planning and Evaluation, HCFA, to
June Gibbs, Inspector General (July 22, 1997) (reprinted in OIG, HOSPICE PATIENTS, supra); see also infra text
accompanying note 88.
22

longer average lengths of stay than non-institutionalized patients thus potentially generating
higher gross revenues than home care patients in the community. Furthermore, the possible
overlap in the services provided by the hospice and nursing home is an opportunity for either
provider to reduce services and costs. Based on the per diem payment system for hospice
services, such reduction in services could result in higher profits.73
According to the OIG, these opportunities may result in illegal inducements to influence
the selection of a hospice in nursing homes whose operators may select the providers with whom
they will contract and restrict residents to one or two providers. The OIG identified several
benefits offered by hospices to nursing homes as potential kickbacks designed to influence the
referral of patients, including:
•

"room and board” payments to the nursing home in amounts in excess of what the
nursing home would have received directly from Medicaid had the patient not been
enrolled in hospice, i.e., greater than 100 percent of the facility's Medicaid rate;

•

payments to the nursing home for "additional" services that Medicaid considers to be
included in its room and board payment to the hospice;

•

referring hospice patients to a nursing home to induce the nursing home to refer its
patients to the hospice;

•

providing free (or below fair market value) hospice care (“bridge services”) to nursing
home patients for whom the nursing home is receiving Medicare payment under the
skilled nursing facility benefit, with the expectation that after the patient exhausts the
skilled nursing facility benefit, the patient will receive hospice services from that hospice;
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See Publication of OIG Special Fraud Alerts: Fraud and Abuse in Nursing Home Arrangements With Hospices,
63 Fed. Reg. 20,415, 20,416 (April 24, 1998) [hereinafter OIG Special Fraud Alert].
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See id.
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•

providing staff at its expense to the nursing home to perform duties that otherwise would
be performed by the nursing home.74

Violation of the anti-kickback statute carries with it the possibility of criminal prosecution, civil
monetary penalties, and may also lead to exclusion from federal health care programs.75
A subsequent OIG Advisory Opinion tempered the impact of the 1998 Fraud Alert by
concluding that the OIG would not subject a hospice to sanctions where the hospice was
providing services, at below market value, to nursing home patients not enrolled in hospice when
the services were being provided by unpaid volunteers, were supporting a vulnerable population,
and resulted in benefits that would be considered primarily “intangible and psychic.”76 While this
Opinion was encouraging to the hospice industry, a subsequent Opinion, discussed above, may
have added to the confusion created by the possibility of overlapping services (the provision of
drugs) covered under both the MHB and the Medicaid “room and board” per diem.77
Empirical Data on Chilling Effect
While there are no definitive data on the impact of these practices and policies on nursing
home referrals to hospice, a study conducted in 2001 and 2002 in the state of Maryland sought to
better understand the effect of financial and fraud and abuse concerns on nursing home/hospice
contractual relationships. Researchers interviewed representatives from 89% of hospices and
43% of nursing homes in the state. The majority of hospice respondents were aware of the Office
of Inspector General’s Special Fraud Alert regarding the relationships between hospices and
nursing homes. Of those, half thought the fraud alert had made a difference in the way they
provided services. Several hospice respondents clearly articulated their belief that the rules are an
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obstacle in some cases to providing good end-of-life care to terminally ill patients in nursing
homes. This seemed to be especially true for patients who were not enrolled in hospice but who
may have been receiving the Medicare SNB or were simply receiving custodial care under
Medicaid but who could benefit from hospice services in pain management and palliative care.
In these cases, some hospice representatives asserted that they had provided the free service in
the past, not as an inducement for referrals, but simply because they are committed to providing
quality end-of-life care, or as one respondent said, because “it’s the right thing to do.”78
As regards concerns about reimbursement and finances, respondents confirmed assertions
in the literature that nursing homes perceive that the MHB is financially disadvantageous. At
least for some residents, the facility would receive more comprehensive reimbursement under the
Medicare skilled nursing benefit (SNB) than it would receive if the resident elected the MHB
and the facility received either the state Medicaid per diem or its private pay per diem.79
UNINTENDED CONSEQUENCES OF COLLATERAL POLICIES
For the most part, the government policies and practices discussed, at least as initially
conceived, had laudable goals that did not attempt to address inadequate care of the dying. For
example, nursing home regulations that encourage improvement in functional level were put in
place in response to conditions at many nursing homes which historically did little to engage
residents or improve their quality of life but simply served as “way stations” where people were
warehoused before death. The regulations were part of the federal Nursing Home Reform Act of
1987 for which advocates for nursing home residents fought hard and long. They have largely
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been viewed as successful in improving the quality of life for many nursing home residents and
should not be displaced or “watered down” for those residents who can benefit from them.
Similarly, the fraud and abuse rules were motivated by an effort to combat fraud and the
practices of providers who “bilk” the system by providing care that is not warranted or
beneficial. Without efforts to control such abuses the underlying integrity of the Medicare and
Medicaid programs is threatened.
The reimbursement mechanisms for nursing homes and hospice have at their root goals
of efficiency and administrative ease. The per diem payment structures for each bundle together
a package of services that have been determined to be necessary for different categories of
patients – hospice, skilled nursing, and custodial care. This aggregation of services primarily
serves to simplify billing from what otherwise could be an overwhelming administrative task on
the part of providers and payers.
Finally, the six month eligibility criteria for hospice was put in place for administrative
simplicity as well as to limit costs of the benefit. The goals of Congress in establishing the
benefit were dual: to serve as “both a cost-containment mechanism to limit the program’s high
costs for beneficiaries in their last year of life and a quality improvement tool to improve care for
the dying.”80
Despite these valid goals, the policies and practices of the agencies implementing and
enforcing them have arguably had the unintended consequence of chilling utilization of hospice
services for dying nursing home residents. The incentives created by the constellation of these
practices encourage: 1) rehabilitation over palliation, even for dying patients; 2) delayed hospice
referral, or 3) no hospice referral or palliative care. Persons with chronic terminal illnesses such
as dementia, congestive heart failure, and chronic lung disease, for which it is difficult to predict
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life expectancy, are particularly disadvantaged by these practices. To the extent that they are
referred to hospice, it is likely that they will be referred late in the course of their illness.81
SHIFTING THE PARADIGMS
While the policies and practices at issue were admittedly based on commendable goals,
they have at their root assumptions that may not be valid or may be based on incomplete
information. The focus of the nursing home regulations on improvement and maintenance of
health and function ignores the fact that more and more individuals are dying in long term care
facilities. Recent data (2001) from the National Center for Health Statistics indicates that in that
year nursing homes were the place of death for over 40% of individuals over the age of 85.
Moreover, over one-third of all people entering nursing facilities will die within 12 months of
admission.82 As a result, while regulators should not abandon the goal of physical improvement
for nursing home residents who can benefit from aggressive rehabilitation and restoration of
function, they can no longer be single minded about this objective. As some have pointed out,
this focus “can add greatly to the suffering of a dying resident.” 83 Government policy makers
and regulators need to move from a model that focuses on rehabilitation and excludes palliation
to one that makes some accommodation for dying individuals.
The paradigm of death as a well defined event, which underlies the hospice benefit’s
rules and reimbursement criteria requiring an individual to choose between curative and
palliative care, also needs to shift to one in which death is recognized as a process during which
“mixed management”, i.e., both palliative and curative care are appropriate. Such an approach
moves away from a model in which these two forms of care are viewed as mutually exclusive to
one in which there is a recognition of interventions that can “sometimes prolong life, sometimes
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palliate, and sometimes do both.”84 The concept is not new and was advocated by the Institute of
Medicine in its 1998 report, Approaching Death: Caring at the End-of-Life.85 The model that
embraces death as a process, also acknowledges that death has different trajectories, some of
which are relatively predictable others which are not. The latter has typically included deaths
from chronic diseases marked by slow decline “punctuated by crises, one of which may prove
fatal.”86 Health care providers in nursing facilities may understand that individuals in these latter
categories have a progressive disease that will lead to death, but they may not see them as dying
or as appropriate for hospice.
Finally, we need to adjust the perspective underlying the enforcement of fraud and abuse
laws in the context of underutilized services. The OIG’s exclusive focus on “over utilization”
should shift to one that takes account of inadequate utilization. This does not mean that the OIG
should abandon its efforts to root out fraud and abuse but rather that the agency should modify
the way it goes about enforcing the fraud and abuse rules in the context of services that are
significantly underutilized. In drafting its fraud alert on nursing home/hospice arrangements, the
OIG made a number of assumptions about nursing home/hospice behavior that would lead to
over utilization without due consideration of the incentives for underutilization.
In the alert, for example, the OIG assumed that nursing home patients were attractive to
hospice because they represent “a sizeable pool of potential hospice patients” with longer
average lengths of stay than non-institutionalized patients, thus potentially generating higher
gross revenues than home care patients in the community. The OIG also asserted that 1) the
potential for overlap in services between the two providers creates an opportunity for either
provider to reduce services and costs and thereby, under a per diem reimbursement system,
84
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increase profits/revenues for either or both; 2) if there is more than one hospice patient in a
nursing facility the hospice may save costs as a result of economies of scale; and 3) nursing
homes have the ability to limit the number of hospices, and choose those hospices, with which
they will contract enabling them to hold out for the “highest bidders” or contract only with those
that will lead to greater financial remuneration.87
While each of these incentives arguably exists, there is evidence that the OIG’s
assumptions about the providers’ behavior in this context may have been based on inaccurate or
limited data and have limited generalizability. For example, a 2000 report prepared for DHHS
characterized the OIG’s assertions of longer hospice lengths of stay in nursing homes as most
likely a result of a sampling bias in its survey of hospice programs.88 Although there are not
definitive data on whether the average hospice length of stay for nursing home patients is greater
or less than for patients in the community, recent data suggest that length of stay may be lower
than average for patients with certain diagnoses that are more common for nursing home
residents such as dementia and other non-cancer conditions as it is often difficult to predict life
expectancy for this group. As a result, physicians may not refer to hospice until death is very
close at hand.89
Moreover, the OIG provides scant evidence for its assertion that hospice or nursing
homes may skimp on services because of potential overlap in patient care. While the OIG found
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in its 1997 report that hospice patients in nursing homes received less nursing, aide and social
work visits and more pastoral care visits than those in the community, this was based on data
from only 22 hospices and 200 nursing home residents receiving hospice benefits.90 In contrast, a
recently published study on site of care and hospice visit volume based on data collected in 1998
and 1999 from 21 hospices and 15,484 hospice patients found no “meaningful difference
between the total average daily visit volumes in nursing homes versus non-nursing home
settings.”91 And, while economies of scale may exist when a hospice has a “critical mass” of
patients in a single facility, the cost savings from reduced transportation costs must be balanced
with the additional costs to both providers of coordinating care between the two.92 As regards
the likelihood that nursing homes will cut back services if hospice personnel are caring for their
residents, the nursing home regulations are clear that nursing facilities must provide Medicare
and Medicaid covered services to all residents regardless of source of payment.93
With respect to the OIG’s assumption that nursing homes can “pick and choose” among
hospices, referring to those that will give them the best “deal,” this would depend on the
geographic area in which the hospice operates. In many cases, a nursing home has few hospices
within its geographic catchment area from which to choose. In some rural areas there may be
none or only one hospice within a reasonable distance. While these figures do not obviate
concerns about contracting incentives in urban areas, they do call into question the ability of
nursing homes in some locations to favor one hospice over another.
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In addition to the questionable assumptions underlying the OIG fraud alert, it appears that
the OIG may have failed to take account of the more weighty financial and non-financial
incentives for nursing homes not to refer residents to hospice. When these other obstacles are
taken into account, in particular the financial disincentives to nursing homes for utilization of
hospice,94 they call into question the hypothetical financial incentives that underlay the fraud
alert and suggest that they may not be nearly as important an influence as the perceived barriers
and disincentives to hospice utilization.
REALIGNING THE INCENTIVES AND FINDING THE RIGHT BALANCE
Policies that Recognize that Palliation and Rehabilitation can Coincide
In its comprehensive report on end-of-life care, published in 1997, the IOM concluded
that the “traditional conceptualization” of end-of-life care as encompassing a transition from
“cure to care” was too limited and may be disadvantageous to many dying patients. These
patients may benefit from a combined approach that incorporates efforts to extend life, either
through curative or life prolonging palliative care, with efforts to prepare the patient and his
family for the patient’s death. The drafters argued that such a combined approach to care
“reflects the reality and ideal of end-of-life care in which therapies are not rigidly divided into
preventive, curative, rehabilitative, palliative, and other categories but are creatively considered
for their potential benefit (or burden) regardless of a patient’s prognosis.”95
Implementing a policy that embraces both palliation and rehabilitation requires changes
to the financial incentives that exist in the current reimbursement system. This can be done
through an incremental approach or a wholesale restructuring of the hospice benefit. One
incremental approach would be to allow more flexibility under the MHB and provide hospice
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These include the loss of a higher rate of reimbursement if a resident is also eligible for the Medicare skilled
nursing benefit.

31

with lower levels of reimbursement for providing partial benefits to nursing home residents, such
as pain management.96 This would allow supportive care to persons with terminal illness who
may still be receiving treatment. Others have suggested a similar approach, arguing that the
exclusive benefits provided under hospice deny some patients needed palliative care.97 While the
Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA) § 512,
provides for separate reimbursement for initial evaluation of pain and symptom management for
a non-hospice patient by a hospice physician, the provision does not allow for reimbursement of
ongoing consultation or provision of services by hospice staff.98
Incentives for patients to elect the skilled nursing benefit over the hospice benefit could
also be achieved by providing a room and board benefit to patients in the nursing home who are
not eligible for Medicaid and who elect the MHB. This would address the current disparity
between the skilled benefit, which covers room and board, and the MHB, which does not, and
put the two options on more equal footing when a nursing home resident must decide, after
hospital discharge, which benefit to choose. This could be done simply as an add-on to the MHB,
which the hospice could pass on to the nursing home, or it could be accomplished by establishing
a RUGs category for palliative care. Under this latter alternative, nursing home staff could
provide the palliative care or a nursing facility could contract with a hospice to provide the
services. While this reimbursement scheme might provide the necessary financial incentive for
nursing homes to provide this service, it does not deal with the need for better training of nursing
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home staff in end-of-life care. Any policy change to encourage nursing homes to take on this
task must address this issue.99
A more fundamental reform would be to establish a new benefit that combines elements
of the SNB and MHB. In the commercial insurance market, recognizing that patients and their
physicians often have difficulty choosing between palliative and curative care, both Aetna and
Kaiser Permanente have recently established a benefit that allows patients who are terminally ill
to receive both benefits at the same time.100 The need for a more flexible approach to the
treatment of dying patients has been recognized by several researchers and practitioners who
“point out that as patients become ill and transition toward death, the need for curative care
gradually declines and the share of services devoted to palliative care gradually rises; there is no
fixed point in time when all care should shift from curative to palliative.”101
Tempering Enforcement Actions to Consider Underutilization
The 1998 fraud alert on nursing home hospice contractual relationships provides an
opportunity to examine the OIG’s approach to fraud enforcement in the context of underutilized
and needed health care services. The utilization of hospice services arguably replicates a
pervasive concern in American medicine – one in which evidence that needed services may be
provided in an excessive or inappropriate manner by providers who are primarily interested in
maximizing their revenues is juxtaposed with evidence that these services are, for a variety of
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other reasons, not adequately provided to those who need them. While fraudulent actions on the
part of any health care provider may negatively affect the “integrity” of the Medicare and
Medicaid programs, in the context of “over utilization” of hospice services, the cost to the
programs is likely very low while the cost of underutilization of hospice care to dying nursing
home residents is arguably very high, i.e., unnecessary pain and suffering at the end-of-life. In
this context, efforts to control fraud may actually undermine quality of care or access to care.
The OIG uses fraud alerts “as a vehicle to identify fraudulent and abusive practices
within the health care industry.”102 Many of the alerts are disseminated only internally to the
OIG’s Office of Investigations and other sections of DHHS. However, a number of alerts are
also distributed to the general public in “keeping with the OIG’s goal and intent of publicizing its
concern about possible widespread and abusive health care industry practices.”103 These public
alerts are issued relatively infrequently. During the past ten years, only seven such alerts were
issued.104 The 1998 fraud alert regarding nursing home/hospice contractual relationships was an
industry wide alert disseminated broadly to providers and the general public.105
As a result of the financial incentives identified by the OIG for nursing homes to enter
into contracts with hospice, in its industry wide fraud alert the OIG identified several abusive
behaviors, in particular “kickbacks” from hospices to nursing homes to induce referrals to
hospice, in which nursing homes and hospices might engage. These included excessive payments
for “room and board” (above 100% of the Medicaid per diem), additional payments for services
that the nursing home should already be providing as part of room and board, referring hospice
patients to the nursing home, and providing “bridge services” to nursing home patients who are
potential hospice patients at rates that are below market value.
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While one could definitely argue that paying nursing homes above 100% of the Medicaid
per diem and paying them for services for which they are already paid under the Medicaid room
and board per diem are done with an intent to defraud, the other actions, i.e. referring patients to
nursing homes and providing “bridge services,” certainly could be done to provide patients with
better care. Thus, while some of the actions identified by the OIG would in most cases be clearly
fraudulent, as a policy matter it is questionable whether an industry wide alert is necessary or
appropriate when: 1) the services at issue are generally underutilized, 2) the incentives for
engaging in such actions are low when compared to the disincentives, and 3) when, as a result,
only a small fraction of the industry may be engaging is such practices.
Moreover, it would seem appropriate to consider the adverse effects of a broad based
(industry wide) alert as compared to a more limited approach that would individually target
potential wrongdoers. In the context of nursing home/hospice care, an industry wide fraud alert
may undermine broader programmatic goals of providing necessary and beneficial end-of-life
care for dying patients and reducing unnecessary Medicare and Medicaid expenditures.106
To the extent that the fraud alert further contributed to underutilization of hospice
services in the nursing home setting, it may have negatively affected quality of care. A number
of studies have shown that many nursing home residents are not receiving adequate end-of-life
care, including pain treatment and other symptomatic care.107 Furthermore, it is unlikely that
patients who, according to the OIG, inappropriately received hospice care were harmed. The
additional services provided by hospice would seem to be inherently benign unless one could
argue that the individual was being denied services that he/she would otherwise want and need or
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that discussions about death and dying would have a negative psychological impact upon an
individual who is not actively dying.
As regards the second programmatic goal of reducing unnecessary government health
care expenditures, while one recently published study found that Medicare expenditures in the
last year of life were greater for hospice patients who were older than 84 and who had diagnoses
other than cancer,108 the study did not specifically address nursing home residents and was
limited to Medicare costs. A second, more recently published study, focusing on end-of-life
expenditures for nursing home residents, found that overall Medicare and Medicaid spending for
dying nursing home residents was not greater for hospice than non-hospice residents and that
“overall, total government expenditures in the last month of life were significantly less for
hospice versus non-hospice residents.”109 Moreover, patients who received the SNB when they
could have received the MHB likely cost the Medicare program more than if they had been
initially referred to hospice.
The challenge to the OIG is to create rules that deter the small number of providers who
are engaging in “fraud” but that do not discourage other providers who are trying to “do the right
thing” from providing a necessary and beneficial health service. Achieving the correct balance is
certainly not a task uniquely within the domain of the OIG; it applies to all regulators. Yet, with
regard to a regulation that is enforceable via criminal penalties, there is arguably a stronger
reason to “get the balance right,” as the chilling effect of a rule punishable as a crime would
seem to be much greater than one with only civil penalties.
In calculating the “right balance” between the joint goals of deterrence of “fraudulent”
behavior and adequate provision of health care services, we would argue that the OIG should not
only consider the costs associated with over utilization of health care services but also consider
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the costs of the effect of rules which “over deter.” In the context of use of hospice services by
nursing homes, such costs may include those borne by terminally ill residents in nursing homes
who are not being adequately treated for their pain or other symptoms, are inappropriately
restrained, tube fed, or hospitalized. This may call for a more fine-tuned approach by the OIG
generally and consideration of more targeted enforcement and fewer industry-wide fraud alerts.
Such broadly targeted pronouncements may have a chilling effect on an entire industry, whose
appropriate services, as a policy matter, we do not want to discourage. Moreover, an industry
wide approach does not take into consideration variations among different geographic
jurisdictions that may affect quality and access to services.
CONCLUSION
This article sought to examine the government policies and practices that deter hospice
use in the long term care setting, the assumptions underlying those policies, and the unintended
consequences they have for dying nursing home residents. Given that some of the assumptions at
the root of these policies are outdated, unfounded, or based on a failure to take into account the
broader context of underutilization of hospice services in nursing homes, we argue for a shift
from existing paradigms that encourage rehabilitation and curative care for dying nursing home
patients when they may benefit from palliative care; that delay palliative care until the patient
can often no longer benefit from such care; and that focus on over utilization to the exclusion of
underutilization in the context of enforcement initiatives. In order to address the negative impact
of these practices, we call for a restructuring of the existing incentives and an effort to balance
(1) the need for rehabilitation with that for palliation; (2) concerns about “overspending” on the
hospice benefit with consideration of the overall savings to the health care system from greater
use of palliative care; and (3) efforts to weed out fraudulent and abusive over utilization of
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services with the impact of those efforts on undermining broader goals of providing quality endof-life care.
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